Gandara DR - Search Results

1

Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.

Semrad TJ, Kim EJ, Tanaka MS, Sands J, Roberts C, Burich RA, Li Y, Gandara DR, Lara P Jr, Mack PC. Semrad TJ, et al. Among authors: gandara dr. Cancer Treat Res Commun. 2017;10:21-26. doi: 10.1016/j.ctarc.2016.12.002. Cancer Treat Res Commun. 2017. PMID: 28736761 Free PMC article.

2

Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study.

Perez EA, Scudder SA, Meyers FA, Tanaka MS, Paradise C, Gandara DR. Perez EA, et al. Among authors: gandara dr. J Immunother (1991). 1991 Feb;10(1):57-62. doi: 10.1097/00002371-199102000-00008. J Immunother (1991). 1991. PMID: 2012799

3

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Among authors: gandara dr. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

4

RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.

Mack PC, Gandara DR, Bowen C, Edelman MJ, Paglieroni T, Schnier JB, Gelmann EP, Gumerlock PH. Mack PC, et al. Among authors: gandara dr. Clin Cancer Res. 1999 Sep;5(9):2596-604. Clin Cancer Res. 1999. PMID: 10499638

5

Gemcitabine/carboplatin combination regimens: importance of dose schedule.

Gandara DR, Lau DH, Lara PN Jr, Edelman MJ. Gandara DR, et al. Oncology (Williston Park). 2000 Jul;14(7 Suppl 4):26-30. Oncology (Williston Park). 2000. PMID: 10960942 Free article. Review.

6

Evolution of combined modality therapy for stage III non-small-cell lung cancer.

Gandara DR, Edelman M, Lara P, Roberts P, Leigh B. Gandara DR, et al. Oncology (Williston Park). 2000 Jul;14(7 Suppl 5):35-41. Oncology (Williston Park). 2000. PMID: 10981289 Review.

7

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.

Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J. Lau D, et al. J Clin Oncol. 2001 Jan 15;19(2):442-7. doi: 10.1200/JCO.2001.19.2.442. J Clin Oncol. 2001. PMID: 11208837 Clinical Trial.

8

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Lara PN Jr, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. Lara PN Jr, et al. Among authors: gandara dr. J Clin Oncol. 2001 Mar 15;19(6):1728-33. doi: 10.1200/JCO.2001.19.6.1728. J Clin Oncol. 2001. PMID: 11251003

9

Gemcitabine in combination with new platinum compounds: an update.

Gandara DR, Edelman MJ, Lara PN, Lau DH. Gandara DR, et al. Oncology (Williston Park). 2001 Mar;15(3 Suppl 6):13-7. Oncology (Williston Park). 2001. PMID: 11301843 Free article. Review.

10

Neoadjuvant therapy for non-small cell lung cancer.

Gandara DR, Lara PN Jr, Goldberg Z, Roberts P, Lau DH. Gandara DR, et al. Anticancer Drugs. 2001 Feb;12 Suppl 1:S5-9. Anticancer Drugs. 2001. PMID: 11340902 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters